News

Accord have told us that they have an expected re-supply date for Accord levetiracetam 250mg, 500mg and 750mg tablets of October 2025.
Epilepsy Action Northern Ireland welcomes the Regional Review of Neurology Services in Northern Ireland and urges the Department of Health to take urgent action to address the serious challenges ...
Three batches of the Zydus Pharmaceuticals topiramate have been reported to have an error on the packaging and patient information leaflet.
School’s been out for summer for a couple of weeks now, and you might be thinking about a summer holiday with your family, travelling around with friends or even just a quick get-away. Epilepsy can ...
Kami Kountcheva & Jayme Creswell | We share travel tips from people with epilepsy and their families to help you have a safe and smooth holiday School’s been out for summer for a couple of weeks now, ...
A major milestone in epilepsy care has been reached in the UK. The first patient has received the EASEE® implant at the Royal Victoria Infirmary in Newcastle. This new treatment is now available on ...
Olivia Colman CBE is an Academy Award, BAFTA, Primetime Emmy & Golden Globe winning actress, best-known for her roles in projects such as Fleabag, The Favourite, Broadchurch, Paddington in Peru, Wonka ...
A new US study finds link between gabapentin use in people with chronic nerve pain and a higher risk of dementia.
Epilepsy Action has called the lack of compensation after two reports a “scandal”, adding that this has “gone on long enough”. Rebekah Smith, Epilepsy Action chief executive, said: “It is a scandal ...
The My Neuro Survey has found a lack of access to mental health services and financial struggles among people with epilepsy.
A new awareness campaign, launched this week, is shining a light on the discrimination people with epilepsy often face around friendships, dating and work. Epilepsy Action’s ‘If I told you…’ campaign ...
Epilepsy Action has called Brody's seizure in tonight's Coronation Street episode, while detained in STC, a "sad reality".